Valuation : OneSource Specialty Pharma Limited

Market Cap 177B 1.87B 1.62B 1.52B 1.39B 2.59B 2.61B 18.03B 7B 90.52B 7.04B 6.88B 297B P/E 2026
-229x
P/E 2027 * 38.1x
Enterprise Value 188B 1.99B 1.72B 1.62B 1.47B 2.75B 2.77B 19.13B 7.43B 96.05B 7.47B 7.3B 316B EV / Sales 2026
12.7x
EV / Sales 2027 * 8.53x
Free-Float
64.51%
Yield 2026 *
-
Yield 2027 * -
1 day+1.08%
1 week+1.87%
Current month+1.67%
1 month-4.65%
3 months-15.96%
6 months+14.67%
Current year-14.70%
1 week 1,491.1
Extreme 1491.1
1,564
1 month 1,478
Extreme 1478
1,647
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
1,925
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 2024-02-29
Director of Finance/CFO - 2024-07-03
Compliance Officer - 2023-03-13
Director TitleAgeSince
Director/Board Member 65 2021-04-06
Director/Board Member 55 2025-02-26
Director/Board Member 66 2025-06-22
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%+1.87%-17.86% - 1.85B
+0.97%-0.75%+3.51%+18.46% 49.74B
-0.30%-2.88%+429.29%+496.95% 44.98B
+2.13%+0.89%+43.59%+17.61% 42.52B
+0.87%-3.73%+8.96%+73.17% 40.78B
-0.90%-3.67%+14.26%+48.44% 32.89B
+2.71%+6.82% - - 17.09B
+1.68%-4.20%+25.28%+116.83% 16.28B
+1.70%-0.05%+18.53%+28.50% 14.4B
+3.34%-1.13%+80.94%+39.19% 13.48B
Average +1.33%-1.06%+67.39%+104.89% 27.4B
Weighted average by Cap. +1.01%-1.76%+93.07%+123.25%

Financials

2026 2027 *
Net sales 13.41B 142M 123M 115M 105M 197M 198M 1.37B 530M 6.86B 533M 522M 22.53B 21.8B 231M 199M 188M 171M 319M 322M 2.22B 862M 11.14B 867M 848M 36.61B
Net income -1.19B -12.6M -10.87M -10.24M -9.33M -17.44M -17.57M -121M -47.05M -609M -47.32M -46.28M -2B 4.46B 47.2M 40.72M 38.36M 34.95M 65.33M 65.82M 454M 176M 2.28B 177M 173M 7.49B
Net Debt 10.81B 114M 98.69M 92.97M 84.71M 158M 160M 1.1B 427M 5.53B 430M 420M 18.15B 8.86B 93.75M 80.88M 76.19M 69.42M 130M 131M 902M 350M 4.53B 352M 344M 14.87B
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.
Employees
1,412
Date Price Change Volume
26-09-02 ₹1,544.40 +1.08% 136,288
26-09-01 ₹1,527.90 +0.58% 69,898
26-08-31 ₹1,519.10 -0.85% 98,831
26-08-28 ₹1,532.20 +0.97% 32,479
26-08-27 ₹1,517.50 +2.28% 315,066
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,544.40INR
Average target price
2,056.00INR
Spread / Average Target
+33.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock